Jennifer M. Giltnane

Author

Also Known As

Angela Quintana, Giltnane, Jennifer M., J Giltnane, J M Giltnane, J. Giltnane, J. M. Giltnane, Jelle Weseling, Jelle Wesseling, Jennifer Giltnane, Jennifer M Giltnane

285

Publications

13.5K

Citations

H-Index

Concepts

All Affiliations

Yale University Vanderbilt University Dana-Farber Cancer Institute Vanderbilt University Medical Center Memorial Sloan Kettering Cancer Center

About

Jennifer M. Giltnane is an author at Yale University specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	17	7.6K
2	Cell Biology	10	10	6.8K
3	Engineering	1	1	17
4	Health Sciences	1	1	39
5	Biostatistics	1	1	17

Jennifer M. Giltnane

Publications

11.2K

Citations

H-Index

Page 1

	Year	Citations
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells Sanjeev Mariathasan, Shannon J. Turley, Dorothee Nickles, Nature Tumor BiologyCancer ImmunosurveillanceTumour ResponsePd-l1 BlockadeT Cells	2018	5.2K
Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor–Positive Breast Cancer Rinath Jeselsohn, Roman Yelensky, Gilles Buchwalter, Clinical Cancer Research	2014	633
MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation Kyung‐min Lee, Jennifer M. Giltnane, Justin M. Balko, Cell Metabolism Tumor BiologyBreast OncologyMitochondrial FunctionMedicineMitochondrial Oxidative Phosphorylation	2017	625
RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors Sherene Loi, Sathana Dushyanthen, Paul A. Beavis, Clinical Cancer Research	2015	546
Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets Justin M. Balko, Jennifer M. Giltnane, Kai Wang, Cancer Discovery	2013	467
Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer Namrata S. Patil, Barzin Y. Nabet, Sören Müller, Cancer Cell Intratumoral Plasma CellsCancer ImmunosurveillancePd-l1 BlockadeMedicineImmunology	2022	371
Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer Milena Hornburg, Mélanie Desbois, Shan Lu, Cancer Cell Cancer ImmunosurveillanceTumor HeterogeneitySingle-cell DissectionMedicineImmunology	2021	364
High HSP90 Expression Is Associated with Decreased Survival in Breast Cancer Elah Pick, Yuval Kluger, Jennifer M. Giltnane, Cancer Research	2007	352
Single-Cell Dynamics Determines Response to CDK4/6 Inhibition in Triple-Negative Breast Cancer Uzma Asghar, Alexis R. Barr, Ros Cutts, Clinical Cancer Research	2017	274
Therapeutic Ligands Antagonize Estrogen Receptor Function by Impairing Its Mobility Jane Guan, Wei Zhou, Marc Hafner, Cell Signal TransductionEndocrine MechanismMedicineHormonal ReceptorReceptor (Biochemistry)	2019	215

Page 1